Correlation Between Athira Pharma and ACADIA Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Athira Pharma and ACADIA Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Athira Pharma and ACADIA Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Athira Pharma and ACADIA Pharmaceuticals, you can compare the effects of market volatilities on Athira Pharma and ACADIA Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Athira Pharma with a short position of ACADIA Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Athira Pharma and ACADIA Pharmaceuticals.

Diversification Opportunities for Athira Pharma and ACADIA Pharmaceuticals

0.65

Correlation Coefficient

Athira Pharma  ACADIA Pharmaceuticals

Poor diversification

The 3 months correlation between Athira and ACADIA is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Athira Pharma and ACADIA Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACADIA Pharmaceuticals and Athira Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Athira Pharma are associated (or correlated) with ACADIA Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACADIA Pharmaceuticals has no effect on the direction of Athira Pharma i.e., Athira Pharma and ACADIA Pharmaceuticals go up and down completely randomly.

Pair Corralation between Athira Pharma and ACADIA Pharmaceuticals

Given the investment horizon of 90 days Athira Pharma is expected to under-perform the ACADIA Pharmaceuticals. In addition to that, Athira Pharma is 1.9 times more volatile than ACADIA Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. ACADIA Pharmaceuticals is currently generating about 0.02 per unit of volatility. If you would invest  1,632  in ACADIA Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  55.00  from holding ACADIA Pharmaceuticals or generate 3.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Athira Pharma  vs.  ACADIA Pharmaceuticals

Athira Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Athira Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Athira Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

ACADIA Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ACADIA Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, ACADIA Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Athira Pharma and ACADIA Pharmaceuticals

The main advantage of trading using opposite Athira Pharma and ACADIA Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Athira Pharma position performs unexpectedly, ACADIA Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACADIA Pharmaceuticals will offset losses from the drop in ACADIA Pharmaceuticals' long position.

The idea behind Athira Pharma and ACADIA Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.